Compumedics

Compumedics Stock-Based Compensation

The Stock-Based Compensation (SBC) of Compumedics (CMP.AX) as of Oct 17, 2026 is -2.62 M AUD. In the previous year, Stock-Based Compensation (SBC) was -1.53 M AUD — a change of 71.33% (lower).

Stock-Based Compensation

-2.62 MAUD

YoY

71.33%

Last updated:

Stock-Based Compensation (SBC) of Compumedics is 2021 -2.62 M AUD. Stock-Based Compensation (SBC) of Compumedics was 2020 -1.53 M AUD. It decreases by 71.33% lower compared to the previous year.

The Compumedics Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2016
3.84 M AUD
Jan 1, 2017
2.15 M AUD
Jan 1, 2020
-1.53 M AUD
Jan 1, 2021
-2.62 M AUD
The Compumedics Stock-Based Compensation history
YEARStock-Based CompensationYoY
-2.62 MAUD+71.33%
-1.53 MAUD-171.31%
2.15 MAUD-44.04%
3.84 MAUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Compumedics Stock analysis

What does Compumedics do? Compumedics Ltd., headquartered in Melbourne, Australia, operates in the Health Care sector, specializing in the research, development, manufacture, and distribution of medical equipment. The company employs 135 full-time staff and serves global markets across the Americas, Australia, Asia Pacific, and Europe and the Middle East. Its product portfolio includes sleep diagnostic systems, clinical EEG systems, brain monitoring solutions, ultrasonic blood-flow systems, and technical support services. Key offerings encompass Somfit/Somfit Pro, Grael 4K PSG:EEG, and Compumedics Neuroscan for neurology applications and brain research technologies. Compumedics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compumedics stock

Stock-Based Compensation (SBC) of Compumedics is -2.62 M AUD in 2021.

Stock-Based Compensation (SBC) of Compumedics changed from -1.53 M AUD to -2.62 M AUD, representing a 71.33% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Compumedics since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Compumedics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Compumedics

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Compumedics